Ready To Welcome To...
Health Care: Drugs
King Pharmaceuticals Inc. (KG: NYSE)
$14.24 0.00 | 0.00%
02/28/11 - 04:03 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.07 |
| 52 Week High | 0.11 |
| 52 Week Low | 0.05 |
| Avg. Daily Vol. (Mil) | 0.10 |
| Beta (3 year) | 2.36 |
| Share Related Items | |
| Mkt Cap (Mil) | 7.51 |
| Shares Out (Mil) | 115.49 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.60 |
| Current Ratio | 0.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 0.84 |
| Price/Cash Flow | -15.20 |
| Per Share Data | |
| Earnings | -0.07 |
| Sales | 0.00 |
| Book Value | 0.08 |
| Cash Flow | 0.00 |
| Business Summary | |
|---|---|
| An exploration stage Company in the process of exploring its mineral properties and is listed on TSX Venture Exchange, trading under the KG symbol. | |
| General Information | |
| 675 West Hastings Street
Suite 711 Vancouver, BC V6B 1N2 |
|
| www.klondikegoldcorp.com | |
| Industry : Metals & Mining | |
| Sector: Basic Materials | |
| Employees: NA | |
| CEO: Mr. Erich Rauguth | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 0.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -5.30 |
| Return on Investments | -6.50 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with KG
- Portfolio NameUser Type
- UserKJP Save Stockpickr Fund
- Contributor10 Worst-Performing S&P...
- ContributorDogs of the S&P 500: Mi...
- UserSUPRATRADE HOT STOCKS (BUY ...
- User©SUPRATRADE HOT STOCKS (...
- UserBlue Star
- ContributorFast Money's Options Activi...
- UserTheGrinder
- Userponybiz Portfolio 1
- ContributorBarron's Summary 6-20-09
Latest KG Headlines from TheStreet
- Two Earnings Plays: Stocks Under $10
11.30.10 | 12:11 pm - They Just Don't Get Pfizer! 11.03.10 | 09:11 am
- Biotech Winners: King Pharmaceuticals, Pain Therapeutics 10.12.10 | 05:10 pm
- Stocks Get Slight Lift From Fed Minutes 10.12.10 | 05:10 pm
- Pfizer Adds New Partners Through King Buy 10.12.10 | 11:10 am
- King Pharmaceuticals, Oil Rigs: Hot Trends 10.12.10 | 09:10 am
- Pfizer Buying King Pharma 10.12.10 | 08:10 am
- Pfizer to Buy King Pharma for $3.6B Cash 10.12.10 | 08:10 am
- Stock Futures Fall Ahead of Fed Minutes 10.12.10 | 07:10 am
- Buy Cliffs Natural Resources, United Airlines, AES 08.10.10 | 10:08 am
Press Releases for KG
- Klondike Gold Corp. Advances Consolidation Of Yukon Mining Interests - Business Wire 04.05.12 | 07:04 pm
- REMOXY® New Drug Application Accepted By The FDA With PDUFA Goal Date Of June 23, 2011 - PR Newswire 01.27.11 | 08:01 am
- REMOXY® New Drug Application Resubmitted - PR Newswire 12.27.10 | 07:12 am
- Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc. - PR Newswire 12.15.10 | 05:12 pm
- Pfizer Commences Tender Offer For All Outstanding Shares Of King Pharmaceuticals, Inc. - PR Newswire 10.22.10 | 08:10 am
- The Law Office Of Abe Shainberg Is Launching An Investigation Into The Possible Breaches Of Fiduciary Duty By The Board Of King Pharmaceuticals, Inc. In Connection With The Sale Of The Company To Pfizer, Inc. – KG - Business Wire 10.13.10 | 03:10 pm
- Levetown & Jenkins, LLP Announces An Investigation Of The Acquisition Of King Pharmaceuticals, Inc. By Pfizer, Inc. - Business Wire 10.12.10 | 11:10 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of King Pharmaceuticals - Business Wire 10.12.10 | 09:10 pm
- Finkelstein Thompson LLP Announces Investigation Of King Pharmaceuticals Inc. - Business Wire 10.12.10 | 09:10 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of King Pharmaceuticals, Inc. - Business Wire 10.12.10 | 08:10 pm
Partner Headlines for KG
- Brandes Global Equity Fund Deep Value Stocks to Consider - Seeking Alpha 03.23.11 | 09:03 am
- Merger Arbitrage Mondays: March 07, 2011 - Seeking Alpha 03.07.11 | 09:03 am
- Pfizer Expands Animal Health Biz - Analyst Blog - Zacks 01.04.11 | 09:01 am
- UPDATE 1-King Pharma resubmits abuse-proof pain drug application - Reuters 12.27.10 | 08:12 am
- King Pharma Files NDA for Pain Drug - Analyst Blog - Zacks 12.21.10 | 09:12 am
- Superstars F5, Netflix Join S&P 500 - Can They Deliver in 2011? - Seeking Alpha 12.10.10 | 07:12 pm
- Endo Pharma Takes Over Qualitest - Analyst Blog - Zacks 12.02.10 | 05:12 pm
- Endo Pharma Takes Over Qualitest - Analyst Blog - Zacks 12.02.10 | 05:12 pm
- Pharma & Biotech Industry Outlook - Nov. 2010 - Industry Outlook - Zacks 11.09.10 | 05:11 pm
- Pfizer Beefs Up Pain Portfolio With King Pharma Buy - Seeking Alpha 10.13.10 | 09:10 am
